Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Cynata Therapeutics Limited
Cynata Therapeutics Limited
CYP · ASX

Cynata Therapeutics Limited

AU$0.26

Price Arrow0.01 (3.92%)
12/12/2025 04:10:09 PM
All-CompaniesAll-ConsensusGROWTH AUSHALO Consensus ValueHALO Earnings MomentumHALO MomentumHALO Ords
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Cynata Therapeutics Limited Overview

CYP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CYP

icon

Telephone

61.3.7067.6940

icon

Address

Level 3, 100 Cubitt Street, Cremorne, Victoria (VIC) 3121

Description

Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on proprietary mesenchymal stem cell technology. Its products include CYP-001, CYP-004, and CYP-004. The company was founded on March 12, 2003 and is headquartered in Cremorne, Australia.

CYP Price Chart

Key Stats

Market Cap

AU$60.55M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.14 - 0.3

Trade Value (12mth)

AU$12,431.00

1 week

0%

1 month

8.16%

YTD

10.42%

1 year

47.22%

All time high

4.60

Key Fundamentals

EPS 3 yr Growth

20.50%

EBITDA Margin

0.00%

Operating Cashflow

-$9m

Free Cash Flow Return

-132.10%

ROIC

-142.30%

Interest Coverage

0.00

Quick Ratio

4.40

Other Data

Shares Outstanding (Fully Diluted)

226m

HALO Sector

Healthcare

Next Company Report Date

31-Aug-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CYP Announcements

Latest Announcements

DateAnnouncements
04 December 25
01 December 25
01 December 25
01 December 25
01 December 25

CYP Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.1-0.05-0.05locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.1-0.05-0.05locklocklock
Growth
%locklocklocklock-158.944.915.5locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

0

7 Day Change

0.00%

1 Month Change

0.00%

3 Months Change

0.00%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CYP Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
The current share price of Cynata Therapeutics Limited (CYP:ASX) is AUD$0.26.
What is the 52-week high share price for Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
The 52-week high share price for Cynata Therapeutics Limited (CYP:ASX) is AUD$0.30.
What is the 52-week low share price for Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
The 52-week low share price for Cynata Therapeutics Limited (CYP:ASX) is AUD$0.14.
What is the dividend yield for Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
Cynata Therapeutics Limited (CYP:ASX) does not pay a dividend.
What was Cynata Therapeutics Limited (CYP:ASX) last dividend payment?
Halo FAQ
Cynata Therapeutics Limited (CYP:ASX) does not pay a dividend.
What is the franking level for Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
Cynata Therapeutics Limited (CYP:ASX) has a franking level of 0.00%.
In which sector is Cynata Therapeutics Limited (CYP:ASX) classified?
Halo FAQ
Cynata Therapeutics Limited (CYP:ASX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.